Reuters logo
3 years ago
BRIEF-Addex Therapeutics amends mGlu2PAM collaboration agreement and receives u$757,000
December 17, 2014 / 7:07 AM / 3 years ago

BRIEF-Addex Therapeutics amends mGlu2PAM collaboration agreement and receives u$757,000

Dec 17 (Reuters) - Addex Therapeutics Ltd :

* Amends mGlu2pam collaboration agreement and receives $757,000

* Has received $757,000 from Janssen Pharmaceuticals Inc., following an amendment of their mGlu2pam research collaboration and license agreement Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below